Immunotherapy for Childhood Acute Lymphoblastic Leukemia

This template maps immunotherapy targets for childhood acute lymphoblastic leukemia on a cancer cell interacting with a T cell, showing tyrosine kinase inhibitors, proteasome inhibitors, and antibody-drug conjugates targeting antigens like CD19, CD20, CD22, CD33, and CD52. It also shows CAR T cells and the bispecific antibody blinatumomab engaging CD3 on T cells to bring them into contact with the tumor-associated antigen.

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.